Synoviocyte adhesion, migration, and proliferation are essential in the growth of pannus and the subsequent invasion of cartilage in inflammatory arthritis. These cellular functions are regulated by the extracellular matrix.' In vitro studies of synoviocytes have previously demonstrated that they display abnormal phenotypic properties, including a transformation-like morphology manifested by cell overlapping and focus formation.2 3 Abnormal synoviocyte phenotype has been shown to be strongly influenced by extracellular matrix; synoviocytes exhibit extensive focus formation when plated on exogenous fibronectin rich matrices or when primed to switch endogenous matrix production from a collagen enriched to a fibronectin enriched type.3 To determine if the influence of matrix on synoviocyte morphology is associated with effects on synoviocyte adhesion and growth, we studied the effect of purified matrix components and a cell free matrix preparation isolated from human synovium on the attachment, spreading, and proliferation of human synoviocytes in vitro.
Synoviocyte adhesion, migration, and proliferation are essential in the growth of pannus and the subsequent invasion of cartilage in inflammatory arthritis. These cellular functions are regulated by the extracellular matrix.' In vitro studies of synoviocytes have previously demonstrated that they display abnormal phenotypic properties, including a transformation-like morphology manifested by cell overlapping and focus formation.2 3 Abnormal synoviocyte phenotype has been shown to be strongly influenced by extracellular matrix; synoviocytes exhibit extensive focus formation when plated on exogenous fibronectin rich matrices or when primed to switch endogenous matrix production from a collagen enriched to a fibronectin enriched type.3 To determine if the influence of matrix on synoviocyte morphology is associated with effects on synoviocyte adhesion and growth, we studied the effect of purified matrix components and a cell free matrix preparation isolated from human synovium on the attachment, spreading, and proliferation of human synoviocytes in vitro.
Materials and methods CELL CULTURE IN SERUM FREE MEDIUM
Synovial samples obtained from patients undergoing total knee replacement surgery for rheumatoid arthritis were placed in explant culture in serum free medium consisting of a 1:1 mixture of Dulbecco's modified Eagle's medium (DMEM) and F12 supplemented with insulin 5 ,ug/ml, hydrocortisone 5 ,ug/ml, epidermal growth factor 5 ng/ml, transferrin 20 1Lg/ml, bovine serum albumin (BSA) 2-5 mg/ml, and penicillin/streptomycin. 
Results

SYNOVIOCYTE ATTACHMENT AND SPREADING
Synoviocyte attachment to all matrix substrata was superior to attachment on tissue culture plastic. There were no significant differences of attachment to collagen I, fibronectin, fibronectin-collagen complexes, or synovial cell free matrix (SCFM): approximately 500/o of cells were attached to matrix at 45 minutes (fig 1) . However, only 30% of synoviocytes plated on plastic had become attached after one hour. When synoviocyte attachment to fibronectin was compared in parallel with the attachment of human laryngeal fibroblasts (LFB), LFB attachment was superior at 45 and 60 minutes (fig 2) . Synoviocyte spreading was enhanced on fibronectin compared with the other matrix substrata. Spreading on all matrices was superior to that on tissue culture plastic (fig 3) . Days in culture Figure 4 Proliferation of synoviocytes and laryngeal fibroblasts on tissue culture plastic andfibronectin substrata (all cells maintained in serum free medium for 28 days). * = Laryngealfibroblasts in fibronectin coated wells; V = synoviocytes in fibronectin coated wells; * = laryn1geal fibroblasts on plastic; A = synoviocytes on plastic.
SYNOVIOCYTE GROWTH
Synoviocytes proliferated for at least 28 days on tissue culture plastic when maintained in serum free defined medium, whereas LFB did not (fig 4) . HFL-1 fibroblasts also did not proliferate under these conditions (data not shown). Synoviocyte proliferation was enhanced by plating on all matrix substrata studied ( fig 5) . SCFM was similar to fibronectin, both matrices showing an approximately threefold increase in synoviocyte proliferation. Proliferation on collagen I enriched matrices was intermediate between that seen on fibronectin or SCFM and plastic; it was increased approximately two-fold.
LFB survived for 14 days under these culture conditions. When plated on extracejlular matrices, these cells displayed enhanced proliferation only on fibronectin ( fig 5) . Specifically, they did not respond to the extracellular matrix purified from synovium (SCFM). attachment was found to enhance proliferation further at 7-10 days (fig 6) . Previous experiments with the RGDS fibronectin cell binding tetrapeptide resulted in cell rounding and detachment.3 Incubation of synoviocytes with the 140 kDa fragment to determine if the antifibronectin effect was attributable to blocking interaction at the RGD dependent cell binding site (fig 7) also resulted in growth inhibition caused by cell rounding and detachment. Taken together, these experiments suggest that abnormal interactions between the synoviocyte and its fibronectin matrix (summarised in figure 9 ) result in abnormal morphology and relative growth inhibition by a mechanism not directly involving the a 5r 1 fibronectin receptor. Immunohistological studies of synovium have revealed a marked increase of fibronectin, collagen VI, and other matrix components in the proliferated intimal lining.1 1-2 It is likely that synoviocyte-matrix interactions are important in regulating synoviocyte proliferation, adhesion, and invasion. The in vitro studies reported here demonstrate that synoviocytes interact differently with various matrix substrata, may differ from other fibroblastic cells in their interactions with matrix components, and have interactions with fibronectin and biomatrices which are complex and likely to involve multiple receptor sites. Studies of synoviocyte-matrix interactions in vitro appear to be useful in the elucidation of mechanisms controlling pannus development and cartilage invasion. 
